Ocugen

1 follower

‌

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.

Industries

Biotechnology

Headquarters

Malvern, United States

Employees

51-200

Links

Org chart

Shankar Musunuri

Chairman, CEO & Co-founder

Shankar Musunuri

Collapse

Arun Upadhyay

Chief Scientific Officer, Head of Research & Development & Medical

Mike Shine

SVP, Commercial

Jyothy Pillai

Head, Regulatory & Quality

Tiffany J. Hamilton

Avp, Head Of Corporate Communications

Daniel Stilp

Senior Accountant

Michael Breininger

Corporate Controller

Kristen Craft

Head Of Human Resources

Teams

Scientific Advisory Team

11 members

Leadership Team

3 members

Finance and Administration Team

6 members

Regulatory and Compliance Team

3 members

Similar companies

Inari

3 followers

Active Motif

3 followers

Generation Bio

2 followers

Vaxart

2 followers

Garuda Therapeutics

4 followers

CHDI Foundation

5 followers

Allakos

1 follower

Helix

9 followers

Thermo Fisher Scientific

173 followers

Neuralink

62 followers

Alexion Pharmaceuticals

34 followers

Explore companies

��������